Recommendation for terminology: Nodules without arterial phase hyperenhancement and with hepatobiliary phase hypointensity in chronic liver disease

for the LI-RADS HBA Working Group

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Level of Evidence: 5. Technical Efficacy Stage: 3. J. Magn. Reson. Imaging 2018;47:1169–1171.

Original languageEnglish (US)
Pages (from-to)1169-1171
Number of pages3
JournalJournal of Magnetic Resonance Imaging
Volume48
Issue number5
DOIs
StatePublished - Nov 1 2018

Fingerprint

Terminology
Liver Diseases
Chronic Disease

Keywords

  • hepatobiliary contrast agent
  • hepatocellular carcinoma
  • liver
  • magnetic resonance imaging

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Recommendation for terminology : Nodules without arterial phase hyperenhancement and with hepatobiliary phase hypointensity in chronic liver disease. / for the LI-RADS HBA Working Group.

In: Journal of Magnetic Resonance Imaging, Vol. 48, No. 5, 01.11.2018, p. 1169-1171.

Research output: Contribution to journalArticle

@article{fde0b64f1fde4bd0a1bd5327d231ab7e,
title = "Recommendation for terminology: Nodules without arterial phase hyperenhancement and with hepatobiliary phase hypointensity in chronic liver disease",
abstract = "Level of Evidence: 5. Technical Efficacy Stage: 3. J. Magn. Reson. Imaging 2018;47:1169–1171.",
keywords = "hepatobiliary contrast agent, hepatocellular carcinoma, liver, magnetic resonance imaging",
author = "{for the LI-RADS HBA Working Group} and Utaroh Motosugi and Takamichi Murakami and Lee, {Jeong Min} and Fowler, {Kathryn J.} and Jay Heiken and Sirlin, {Claude B.}",
year = "2018",
month = "11",
day = "1",
doi = "10.1002/jmri.26515",
language = "English (US)",
volume = "48",
pages = "1169--1171",
journal = "Journal of Magnetic Resonance Imaging",
issn = "1053-1807",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - Recommendation for terminology

T2 - Nodules without arterial phase hyperenhancement and with hepatobiliary phase hypointensity in chronic liver disease

AU - for the LI-RADS HBA Working Group

AU - Motosugi, Utaroh

AU - Murakami, Takamichi

AU - Lee, Jeong Min

AU - Fowler, Kathryn J.

AU - Heiken, Jay

AU - Sirlin, Claude B.

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Level of Evidence: 5. Technical Efficacy Stage: 3. J. Magn. Reson. Imaging 2018;47:1169–1171.

AB - Level of Evidence: 5. Technical Efficacy Stage: 3. J. Magn. Reson. Imaging 2018;47:1169–1171.

KW - hepatobiliary contrast agent

KW - hepatocellular carcinoma

KW - liver

KW - magnetic resonance imaging

UR - http://www.scopus.com/inward/record.url?scp=85055193003&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055193003&partnerID=8YFLogxK

U2 - 10.1002/jmri.26515

DO - 10.1002/jmri.26515

M3 - Article

C2 - 30347132

AN - SCOPUS:85055193003

VL - 48

SP - 1169

EP - 1171

JO - Journal of Magnetic Resonance Imaging

JF - Journal of Magnetic Resonance Imaging

SN - 1053-1807

IS - 5

ER -